BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lambertucci C, Spinaci A, Buccioni M, Dal Ben D, Ngouadjeu Ngnintedem MA, Kachler S, Marucci G, Klotz KN, Volpini R. New A2A adenosine receptor antagonists: a structure-based upside-down interaction in the receptor cavity. Bioorg Chem 2019;92:103183. [PMID: 31446240 DOI: 10.1016/j.bioorg.2019.103183] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Spinaci A, Lambertucci C, Buccioni M, Dal Ben D, Graiff C, Barbalace MC, Hrelia S, Angeloni C, Tayebati SK, Ubaldi M, Masi A, Klotz KN, Volpini R, Marucci G. A2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable? Molecules 2022;27:2386. [PMID: 35458588 DOI: 10.3390/molecules27082386] [Reference Citation Analysis]
2 Saini A, Patel R, Gaba S, Singh G, Gupta GD, Monga V. Adenosine receptor antagonists: Recent advances and therapeutic perspective. Eur J Med Chem 2021;227:113907. [PMID: 34695776 DOI: 10.1016/j.ejmech.2021.113907] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
3 Dal Ben D, Lambertucci C, Buccioni M, Martí Navia A, Marucci G, Spinaci A, Volpini R. Non-Nucleoside Agonists of the Adenosine Receptors: An Overview. Pharmaceuticals (Basel) 2019;12:E150. [PMID: 31597388 DOI: 10.3390/ph12040150] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]